Braizon is developing a drug delivery technology for crossing the Blood Brain Barrier via a Glucose Transporter using polymer nano-particle carriers. Our company objective is the application of revolutionary delivery technologies to improve the lives of people with unmet neurological needs.
Company HQ State:
Company HQ Country:
Main Therapeutic Focus:
Lead Product in Development:
Development Phase of Primary Product:
Number Of Unlicensed Products (For Which You Are Seeking Partners):